Preliminary Investigation Launched into Midtown High-Rise Structural Issues

On July 10, 2026, New York City investigators and Manhattan prosecutors initiated a preliminary criminal inquiry regarding structural issues observed in a Midtown building. A city official and a person familiar with the matter indicated that the inquiry by the New York City Department of Investigation and the Manhattan district attorney’s office was in its nascent stages. The specific focus and targets of the investigation remain unclear, partly because the building is still undergoing stabilization efforts.

The 37-story building located at 235 East 42nd Street is undergoing conversion from office space to residential apartments. On Tuesday, construction workers identified concerning signs on the 21st floor, including cracked concrete floors and bent columns. This prompted immediate evacuations and an emergency response.

The investigation is expected to be complex and resource-intensive. The building, previously the headquarters of the pharmaceutical company Pfizer, is part of what was intended to be the largest residential conversion project in the U.S. Such transformations typically involve multiple companies, subcontractors, and developers, each with distinct roles and responsibilities.

Determining the events leading to the structural compromise and identifying any potential criminal liability could take several months, potentially even years. There is a possibility that the investigation could conclude without the filing of criminal charges.